Special Issue "Molecular Targets and Targeting in Biomedical Sciences"
A special issue of Biology (ISSN 2079-7737).
Deadline for manuscript submissions: closed (30 September 2020) | Viewed by 13610
Interests: bioactive peptides; cell biology; molecular targets; drug discovery; biomedicine; molecular imaging; MRI
Interests: cancer; biology; head and neck; oncoimmunology; prognostic; immunotherapy
Interests: molecular targets; drug discovery; biomedicine; molecular imaging; nanopaticles; theranostic; medicinal chemistry
The personalized medicine endorsed by the remarkable breakthrough of genomic and proteomic technologies during the last decades will hopefully enable the fashioning of preventive, diagnostic, prognostic, and curative medicine, according to the individual’s genetic and molecular profile. Such tremendous progress in biomedical concepts will have an overwhelming impact on patient healthcare, both by preventing or limiting the medication side effects and reducing the healthcare costs as a result of an improved disease outcome.
The biomarkers represent key players in personalized medicine, and they are defined by the FDA-NIH Biomarker Working Group as a measurable molecular signature of normal or pathogenic processes, or as a therapeutic outcome of medical intervention. Among them, molecular biomarkers serve as targets for the development of molecularly targeted imaging probes and therapeutics through a wide range of library-based display technologies. But what are the real progresses, challenges, and perspectives of all of these modern tools of molecular biology for biomedical research in general and for patient care in particular?
This Special Issue welcomes the submission of original research and review manuscripts focusing on biomarkers of interest for the diagnosis, therapy, and theranostics of a wide range of pathologies, but also on the specific technologies employed in their identification and targeting, helping us to achieve a realistic overview of this exciting and interdisciplinary field of biomedical research.
Prof. Dr. Carmen Burtea
Prof. Dr. Sven Saussez
Prof. Dr. Marc Port
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- targeted therapy
- molecular targeting
- imaging probes
- molecular imaging
- library-based display technologies